Chemoinformaics analysis of HEXADECA-TRANS-2-CIS-9-DIENE-12,14-DIYNOIC-ACID-ISOBUTYLAMIDE
| Molecular Weight | 250.382 | nRot | 11 |
| Heavy Atom Molecular Weight | 224.174 | nRig | 4 |
| Exact Molecular Weight | 250.193 | nRing | 0 |
| Solubility: LogS | -4.116 | nHRing | 0 |
| Solubility: LogP | 5.7 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 45.6606 |
| nHD | 1 | BPOL | 26.9514 |
| QED | 0.322 |
| Synth | 2.483 |
| Natural Product Likeliness | 1.526 |
| NR-PPAR-gamma | 0.021 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.032 |
| HIA | 0.007 |
| CACO-2 | -4.78 |
| MDCK | 0.0000265 |
| BBB | 0.749 |
| PPB | 0.978078 |
| VDSS | 0.483 |
| FU | 0.0181612 |
| CYP1A2-inh | 0.146 |
| CYP1A2-sub | 0.546 |
| CYP2c19-inh | 0.044 |
| CYP2c19-sub | 0.513 |
| CYP2c9-inh | 0.235 |
| CYP2c9-sub | 0.875 |
| CYP2d6-inh | 0.012 |
| CYP2d6-sub | 0.258 |
| CYP3a4-inh | 0.014 |
| CYP3a4-sub | 0.089 |
| CL | 0.962 |
| T12 | 0.519 |
| hERG | 0.178 |
| Ames | 0.559 |
| ROA | 0.8 |
| SkinSen | 0.986 |
| Carcinogencity | 0.341 |
| EI | 0.976 |
| Respiratory | 0.942 |
| NR-Aromatase | 0.382 |
| Antiviral | Yes |
| Prediction | 0.786284 |